Overview 24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. Glargine Status: Completed Trial end date: 2004-12-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine if twice-daily Lispro low mixture (75/25) will result in lower post prandial blood glucose readings versus once-daily glargine plus oral diabetic medications. Phase: Phase 4 Details Lead Sponsor: Eli Lilly and CompanyTreatments: Hypoglycemic AgentsInsulin GlargineInsulin Lispro